Patent practice in the Pharmaceutical field

The following table shows contents overview and links.

Pharmaceutical patent practiceLinks
How to write claims regarding methods of treating a disease Click
The limitation of "for use in..." in typical European medical use claims does not contribute to patentability Click
<Article> Case Study: Recently Granted Epitope-Based Antibody Patents in the United States, Europe and Japan Click
<Article> Case Study: Are the Terms ‘Antibody Derivative’ and ‘Bispecific Antibody’ Described in Dependent Claims or Specification of Antibody Patents? Click
Invalidation trials against Ono’s anti-PD-1 antibody patents and anti-PD-L1 antibody patents were filed in Japan Click
History of Avastin (anti-VEGF antibody)-related patents and biosimilar approval Click
Circumstances of Amgen's Repatha (anti-PCSK9 antibody)-related patents Click
List of invalidation trials and oppositions against Biopharmaceutical patents filed between May 2017 and May 2019 Click
Examination Handbook for Medicinal Inventions Click
Examination Handbook for Biological Inventions Click
Patent Law regarding patent term extension in the pharmaceutical field Click
List of patent term extension applications and drugs (on or before 2000) Click
List of patent term extension applications and drugs (2001-2005) Click
List of patent term extension applications and drugs (2006-2010) Click
List of patent term extension applications and drugs (2011-2015) Click
List of patent term extension applications and drugs (2016-2019) Click